Psilocin

Tryptamine Therapeutics Advances Psilocin-Based IV Infusion To Phase 2 Clinical Trials

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment

Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments

FDA Endorses CaaMTech's Psilocin Drug Development For Depression Treatment

Patents Reveal New Prodrugs For Psilocin, Promising Reliable Mental Health Treatments

Michigan Bill Could Legalize Psychedelic Mushrooms For PTSD Treatment

Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder

Michigan Bill Could Legalize Psychedelic Mushrooms For PTSD Treatment

Beckley Psytech Doses First Patients With Psilocin In Trial For Treatment Of Major Depression Disorder

Enveric Biosciences Sells Cancer Patents As It Paves Way For Mental Health Treatments

Next-Generation Psychedelics Shows Promise With Upcoming Clinical Trials

Psilocin Recent News

This Psychedelics Company Is Patenting Its Psilocin And Psilocybin Delivery Route

The World Intellectual Property Organization (WIPO) has published clinical-stage biopharma Tryp Therapeutics Inc. (OTCQB: TRYPF)’s international patent application for the intravenous (IV) administration of psilocybin and psilocin.